Language delay

Poll Shows Increases in Hearing, Speech, and Language Referrals, More Communication Challenges in Young Children

Retrieved on: 
Monday, May 1, 2023
American Speech–Language–Hearing Association, Hearing loss, Social, Audiology, Communication, Speech, Parent, Marie Cassidy, Language delay, Language, Doctor of Philosophy, Disorder, Tablet, ASHA, Hearing, Signs, Diagnosis, Caregiver, Toy

ROCKVILLE, Md., May 1, 2023 /PRNewswire/ -- A new national poll of audiologists and speech-language pathologists who work with children ages birth to 5 years reveals that most respondents have experienced an increase in referrals for concerns about hearing, speech, and language delays or disorders over the past 2 years—a time marked by pandemic-related transformations in the lives of many young children. The poll was conducted by the American Speech-Language-Hearing Association (ASHA), which is releasing its results today as Better Hearing and Speech Month begins.

Key Points: 
  • The poll was conducted by the American Speech-Language-Hearing Association (ASHA), which is releasing its results today as Better Hearing and Speech Month begins.
  • Among speech-language pathologists, 84% report more children with emotional or behavioral difficulties, 79% report more children with delayed language or diagnosed language disorders, and 78% report more children with social communication difficulties than before the pandemic.
  • A majority (71%) said that most families with young children are at least "somewhat" aware of the importance of early detection of speech, language, and hearing difficulties when families first see them.
  • ASHA's poll also found the following:
    Lack of awareness of the early signs of disorders remains the leading factor hindering parents and caregivers from taking action on communication disorders in young children.

Neurocrine Biosciences Presents Demographic and Clinical Characteristics Data of Pediatric Patients with SCN8A-Related Epilepsies at AES 2022

Retrieved on: 
Friday, December 2, 2022
Safety, Child, Language delay, Research, Pharmacokinetics, Clinical trial, Poster, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Patient, AES, Speech, Neurocrine, Neurocrine Biosciences, Brain, SCN8A, Epilepsy, SUDEP, Multimedia, Seizure, SAN, Development of the human body, ASMS, Tardive dyskinesia, Parkinson's disease, CT, KAYAK, Data analysis, Annual general meeting, Genetic testing, Death, Food, COVID-19, Clinical, Government budget balance, Music City Center, Dees, FDA, Genetics, AbbVie, Risk, SD, Pharmaceutical industry, Medical device

SAN DIEGO, Dec. 2, 2022 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX), a leading neuroscience-focused biopharmaceutical company,today reported demographic and clinical characteristics data from genetic screening-based studies of children with SCN8A-related epilepsies.

Key Points: 
  • SAN DIEGO, Dec. 2, 2022 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX), a leading neuroscience-focused biopharmaceutical company,today reported demographic and clinical characteristics data from genetic screening-based studies of children with SCN8A-related epilepsies.
  • Data was collected from more than 17,000 patients through Invitae Corporation's Behind the Seizure Program, of which Neurocrine Biosciences is a sponsor.
  • These data (Poster #2.099: Demographic and Clinical Characteristics of Pediatric Patients with SCN8A-related Epilepsies: Results from a No-Charge Epilepsy Gene Panel) will be shared at the AES 2022 Annual Meeting in Nashville, Tennessee, December 26, 2022.
  • Data analysis demonstrated that 36 (0.2%) of the patients had an SCN8A variant that was classified as pathogenic (P) or likely pathogenic (LP).

CES 2021 PenguinSmart's intelligent and individualized rehab therapy helps children improve speech and language delays

Retrieved on: 
Tuesday, January 12, 2021
Medical specialties, Health sciences, Health, Applied linguistics, Rehabilitation medicine, Communication disorders, Language delay, Speech-language pathology, Therapy, Rehabilitation, Occupational therapist, Atlanta Speech School

PenguinSmart is a digital healthcare startup that enables intelligent, individualized rehab therapy for all.

Key Points: 
  • PenguinSmart is a digital healthcare startup that enables intelligent, individualized rehab therapy for all.
  • Currently, there are not enough rehab professionals to meet the need because rehab therapy requires intensive and customized care.
  • First, their voice-based speech detection can identify speech and language delays in children in just 2 minutes.
  • Last, their online home intervention support services with licensed speech therapists allow parents to follow specialized learning plans for their children to improve their speech and language delays.